Powering the future of temperature-sensitive pharmaceutical logistics Pharma logistics is evolving with biologics and trials, demanding faster, precise, and patient-focused supply chains.

The global pharmaceutical logistics sector is undergoing a transformation, driven by the rise of biologics, clinical trials, and personalized medicine.

#pharmaceutical #Pharma #DHL #DHLSupplyChain #CRYOPDP #MiddleEast #UAE #SaudiArabia

Pharma logistics playbook: M&A muscle, cold-chain infra, real-time tech Pharmaceutical air logistics is undergoing a structural transformation, as mergers, infrastructure investments, and real-time technologies converge to shape a more connected, compliant, and...

Pharmaceutical air logistics is undergoing a structural transformation, as mergers, infrastructure investments, and real-time technologies converge to shape a more connected, compliant, and intelligent global supply chain.

#myGrape #Swissport #DHL #CRYOPDP #Lufthansa

Cryoport Strategically Partners with DHL After Divesting CRYOPDP Cryoport, Inc. has completed the divestiture of CRYOPDP to DHL Group, initiating a strategic partnership to enhance supply chain solutions in life sciences.

Cryoport Strategically Partners with DHL After Divesting CRYOPDP #United_States #Nashville #CryoPort #DHL_Group #CRYOPDP

DHL Group Solidifies Position in Health Logistics by Acquiring CRYOPDP DHL Group has acquired CRYOPDP from Cryoport, enhancing its capabilities in health logistics. This acquisition aligns with DHL's strategic goals for the life sciences sector.

DHL Group Solidifies Position in Health Logistics by Acquiring CRYOPDP #Germany #Bonn #CryoPort #DHL_Group #CRYOPDP

DHL strengthens health logistics, acquires CRYOPDP CRYOPDP is a leading specialty courier providing services for clinical trials, biopharma, and cell & gene therapies.

DHL Group and Cryoport, a global provider of supply chain solutions for the life sciences sector, announced that DHL has acquired 100 percent of #CRYOPDP, a leading specialty courier focused on clinical trials, #biopharma, and cell and gene therapies.

#DHLGroup #Cryoport #DHL #clinicaltrials

Germany’s DHL to acquire US pharma logistics firm Cryopdp DUSSELDORF, Germany (Reuters) -DHL said on Monday it will acquire U.S. pharmaceutical logistics firm Cryopdp as part of the German company’s efforts to grow its operations in the pharma sector, confirming an earlier report by Reuters. DHL did not disclose a purchase price for the deal, which foresees the German logistics giant buying 100% of the specialty courier. A source familiar with the matter told Reuters that DHL would pay a three-digit million-euro sum. The companies have also agreed to a strategic partnership to strengthen their supply chain service offerings for the global life sciences and healthcare sector, DHL said in a statement. Cryopdp ships products for pharmaceutical and biotech companies, as well as offering storage and packaging services. DHL hopes the deal will strengthen its Life Sciences and Healthcare segments, which generated over 5 billion euros ($5.41 billion) in revenue in 2024. ($1 = 0.9247 euros)

Click Subscribe #DHL #PharmaLogistics #Cryopdp #Logistics #Pharmaceuticals

DHL set to acquire U.S. firm Cryopdp for three-digit million-euro sum Blog Mobile Portfolio Widgets About Us Advertise Help & Support Authors Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Click Subscribe #DHL #Cryopdp #PharmaceuticalLogistics #SupplyChain #Acquisition